A Big thanks to Aurigene‘s [colorblind] scientists who have been gracious enough to share with us this presentation given in India at a recent med-chem conference.
Structural Insights into Kinase Inhibition
More like this please!
Posted by kinasepro on May 29, 2009
A Big thanks to Aurigene‘s [colorblind] scientists who have been gracious enough to share with us this presentation given in India at a recent med-chem conference.
Structural Insights into Kinase Inhibition
More like this please!
Posted in General Interest | Leave a Comment »
Posted by kinasepro on May 25, 2009
So just what is an allosteric kinase inhibitor?
Posted in General Interest, gleevec | 8 Comments »
Posted by kinasepro on May 20, 2009
So Bayer is in Ph2 with fluoro-sorafenib aka DAST, BAY-734506… Only this time they’re in without Onyx and I gather Onyx is none too happy about this.
The distinct compound is claimed in WO/2005/009961 and the I believe the original Sorafenib app is: WO/2000/042012. What strikes the chemist inventor about a structure like this isn’t usually about who owns it, but if it can really be considered a new invention? The claim structure in the 2000 Sorafenib application can be schematized:
So for the purpose of this discussion the only meaningful definition is the ring designated as “L” and whether or not they claim the fluoride:
Anyhow while this structure and their priority date may be vulnerable to obviousness, all of these applications are assigned to Bayer, and not Onyx, so that disagreement will more likely be resolved based on the wording of the Onyx / Bayer contract. The Onyx press release suggests this very structure was discovered during the collaboration… We’ll see. Given the timing I bet someone saw the structure here on Kinasepro and told Onyx, heh.
Posted in Bayer, RAF, VEGF | 5 Comments »
Posted by kinasepro on May 18, 2009
an A-loop doesn’t do that! (its new SGC prerelease of a BI-PLK1-like inhibitor bound to TTK)
Posted in PDB, SGC | Leave a Comment »
Posted by kinasepro on May 15, 2009
A likely backup to CG-930, its a Signal discovered JNK inhibitor for which there is a solid forms app: WO/2008/057252
– no mention of stereochemistry –
Posted in Celgene, Jnk | Leave a Comment »
Posted by kinasepro on May 14, 2009
As a comment in another thread notes, they have a handful of these too. The regioismer is the novelty factor:
Posted in Amgen, c-Met | Leave a Comment »
Posted by kinasepro on May 13, 2009
‘Nother Triazolopyridazine c-Met app:
Posted in c-Met, Sanofi-Aventis | Leave a Comment »
Posted by kinasepro on May 13, 2009
mmm KinaseBlogging:
Posted in CDK | Leave a Comment »